Loading clinical trials...
Loading clinical trials...
Probiotics are favorable microorganisms that regulate the flora of the gastrointestinal system and stimulate the immune system. Saccharomyces boulardii was shown to reduce candida colonization. The objective of this study is to evaluate the efficacy of prophylactic S boulardii in reducing the candida colonization and infection in very low birth weight infants.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology
Ankara, Turkey (Türkiye)
Start Date
July 1, 2011
Primary Completion Date
December 1, 2011
Completion Date
December 1, 2011
Last Updated
August 8, 2011
140
ESTIMATED participants
Reflor
DIETARY_SUPPLEMENT
mikostatin
DRUG
Lead Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions